T14 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Watchlist Manager

Watchlist

Price: 2.53 USD 0.4%

Market Cap: $3.6B

T	Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd SGX:T14	CN
	Also Holding AG F:9AS	CH
N	Neogenomics Inc F:NG9	US

Profitability Summary

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is 60/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

42% > 73%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

9% > 18%

Healthy Net Margin

18%

Strong 3Y Average Net Margin

31%

Net Margin is Increasing

12% > 18%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

6% > 15%

Positive ROE

12%

Exceptional 3Y Average ROE

View All

Hide

Collapse

60 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.